The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae

Lancet Infect Dis. 2022 Sep;22(9):1271-1272. doi: 10.1016/S1473-3099(22)00520-5. Epub 2022 Aug 9.

¹ UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4029, Australia.
² World Health Organization Collaborating Centre for STI and AMR, New South Wales Health Pathology Microbiology, The Prince of Wales Hospital, Randwick, NSW, Australia; School of Medical Sciences, The University of New South Wales, Sydney, NSW, Australia.
³ UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4029, Australia; Pathology Queensland Central Laboratory, Queensland Health, Brisbane, QLD, Australia. Electronic address: d.whiley@uq.edu.au.

No abstract available

Publication types